• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Akt亚型:乳腺癌中的家族事务

Akt Isoforms: A Family Affair in Breast Cancer.

作者信息

Basu Alakananda, Lambring Christoffer Briggs

机构信息

Department of Microbiology, Immunology and Genetics, University of North Texas Health Science Center, Fort Worth, TX 76107, USA.

出版信息

Cancers (Basel). 2021 Jul 9;13(14):3445. doi: 10.3390/cancers13143445.

DOI:10.3390/cancers13143445
PMID:34298660
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8306188/
Abstract

Akt, also known as protein kinase B (PKB), belongs to the AGC family of protein kinases. It acts downstream of the phosphatidylinositol 3-kinase (PI3K) and regulates diverse cellular processes, including cell proliferation, cell survival, metabolism, tumor growth and metastasis. The PI3K/Akt signaling pathway is frequently deregulated in breast cancer and plays an important role in the development and progression of breast cancer. There are three closely related members in the Akt family, namely Akt1(PKBα), Akt2(PKBβ) and Akt3(PKBγ). Although Akt isoforms share similar structures, they exhibit redundant, distinct as well as opposite functions. While the Akt signaling pathway is an important target for cancer therapy, an understanding of the isoform-specific function of Akt is critical to effectively target this pathway. However, our perception regarding how Akt isoforms contribute to the genesis and progression of breast cancer changes as we gain new knowledge. The purpose of this review article is to analyze current literatures on distinct functions of Akt isoforms in breast cancer.

摘要

Akt,也被称为蛋白激酶B(PKB),属于蛋白激酶的AGC家族。它在磷脂酰肌醇3激酶(PI3K)的下游发挥作用,调节多种细胞过程,包括细胞增殖、细胞存活、代谢、肿瘤生长和转移。PI3K/Akt信号通路在乳腺癌中经常失调,在乳腺癌的发生和发展中起重要作用。Akt家族有三个密切相关的成员,即Akt1(PKBα)、Akt2(PKBβ)和Akt3(PKBγ)。虽然Akt亚型具有相似的结构,但它们表现出冗余、不同以及相反的功能。虽然Akt信号通路是癌症治疗的重要靶点,但了解Akt亚型特异性功能对于有效靶向该通路至关重要。然而,随着我们获得新知识,我们对Akt亚型如何促进乳腺癌发生和发展的认识也在发生变化。这篇综述文章的目的是分析当前关于Akt亚型在乳腺癌中不同功能的文献。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b55/8306188/d37c7f5e8da3/cancers-13-03445-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b55/8306188/d37c7f5e8da3/cancers-13-03445-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b55/8306188/d37c7f5e8da3/cancers-13-03445-g001.jpg

相似文献

1
Akt Isoforms: A Family Affair in Breast Cancer.Akt亚型:乳腺癌中的家族事务
Cancers (Basel). 2021 Jul 9;13(14):3445. doi: 10.3390/cancers13143445.
2
Distinct functions of AKT isoforms in breast cancer: a comprehensive review.AKT 亚型在乳腺癌中的不同功能:全面综述。
Cell Commun Signal. 2019 Nov 21;17(1):154. doi: 10.1186/s12964-019-0450-3.
3
Functional specificity of Akt isoforms in cancer progression.Akt亚型在癌症进展中的功能特异性。
Biomol Concepts. 2011 Apr 1;2(1-2):1-11. doi: 10.1515/bmc.2011.003.
4
The Akt kinases: isoform specificity in metabolism and cancer.Akt激酶:代谢与癌症中的亚型特异性
Cell Cycle. 2009 Aug 15;8(16):2502-8. doi: 10.4161/cc.8.16.9335. Epub 2009 Aug 23.
5
Protein kinase B: emerging mechanisms of isoform-specific regulation of cellular signaling in cancer.蛋白激酶B:癌症中细胞信号传导异构体特异性调节的新机制
Anticancer Drugs. 2017 Jul;28(6):569-580. doi: 10.1097/CAD.0000000000000496.
6
Dissecting signalling by individual Akt/PKB isoforms, three steps at once.一次性剖析单个Akt/PKB亚型的信号传导,分三步进行。 (注:原英文表述似乎不太完整准确,按字面意思翻译如上,可能需要结合更多上下文来准确理解。)
Biochem J. 2015 Sep 1;470(2):e13-6. doi: 10.1042/BJ20150750.
7
The activation of Akt/PKB signaling pathway and cell survival.Akt/PKB信号通路的激活与细胞存活。
J Cell Mol Med. 2005 Jan-Mar;9(1):59-71. doi: 10.1111/j.1582-4934.2005.tb00337.x.
8
Akt/protein kinase B isoforms are differentially regulated by epidermal growth factor stimulation.Akt/蛋白激酶B亚型受表皮生长因子刺激的调控存在差异。
J Biol Chem. 2000 Oct 6;275(40):30934-42. doi: 10.1074/jbc.M004112200.
9
Functional and therapeutic significance of Akt deregulation in malignant melanoma.Akt失调在恶性黑色素瘤中的功能及治疗意义
Cancer Metastasis Rev. 2005 Jun;24(2):273-85. doi: 10.1007/s10555-005-1577-9.
10
Pharmacoinformatic Approaches to Design Novel Inhibitors of Protein Kinase B Pathways in Cancer.基于药物信息学方法设计新型蛋白激酶 B 通路抑制剂用于癌症治疗。
Curr Cancer Drug Targets. 2018;18(9):830-846. doi: 10.2174/1568009617666170623104540.

引用本文的文献

1
Activation of AKT via a dual mechanism enhances the susceptibility of melanoma cells to glucose deprivation.通过双重机制激活AKT可增强黑色素瘤细胞对葡萄糖剥夺的敏感性。
Cell Death Dis. 2025 Aug 7;16(1):595. doi: 10.1038/s41419-025-07906-4.
2
Mutational analysis and protein expression of PI3K/AKT pathway in four mucinous cystadenocarcinoma of the breast.4例乳腺黏液性囊腺癌中PI3K/AKT通路的突变分析及蛋白表达
Diagn Pathol. 2025 May 28;20(1):68. doi: 10.1186/s13000-025-01650-1.
3
and mutations as drivers of paclitaxel resistance in breast cancer cells.

本文引用的文献

1
The interplay between apoptosis and cellular senescence: Bcl-2 family proteins as targets for cancer therapy.细胞凋亡与细胞衰老的相互作用:Bcl-2 家族蛋白作为癌症治疗的靶点。
Pharmacol Ther. 2022 Feb;230:107943. doi: 10.1016/j.pharmthera.2021.107943. Epub 2021 Jun 25.
2
mTORC2 controls the activity of PKC and Akt by phosphorylating a conserved TOR interaction motif.mTORC2 通过磷酸化一个保守的 TOR 相互作用基序来控制 PKC 和 Akt 的活性。
Sci Signal. 2021 Apr 13;14(678):eabe4509. doi: 10.1126/scisignal.abe4509.
3
Mutations as a Molecular Target for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer.
以及作为乳腺癌细胞中紫杉醇耐药驱动因素的突变。
Oncol Lett. 2025 May 2;30(1):324. doi: 10.3892/ol.2025.15070. eCollection 2025 Jul.
4
Molecular Docking of Lactoferrin with Apoptosis-Related Proteins Insights into Its Anticancer Mechanism.乳铁蛋白与凋亡相关蛋白的分子对接:对其抗癌机制的见解
Int J Mol Sci. 2025 Feb 26;26(5):2023. doi: 10.3390/ijms26052023.
5
Network pharmacology and in silico approach to study the mechanism of quercetin against breast cancer.基于网络药理学和计算机模拟方法研究槲皮素抗乳腺癌的作用机制
In Silico Pharmacol. 2025 Feb 6;13(1):22. doi: 10.1007/s40203-025-00306-8. eCollection 2025.
6
Screening of Oncogenic Proteins and Development of a Multiepitope Peptide Vaccine Targeting AKT1 and PARP1 for Breast Cancer by Integrating Reverse Vaccinology and Immune-Informatics Approaches.通过整合反向疫苗学和免疫信息学方法筛选致癌蛋白并开发针对乳腺癌中AKT1和PARP1的多表位肽疫苗
Asian Pac J Cancer Prev. 2025 Jan 1;26(1):327-338. doi: 10.31557/APJCP.2025.26.1.327.
7
Unveiling the Mechanisms and Therapeutic Effects of Xiaoyao Sanjie Decoction in Triple-Negative Breast Cancer: A Network Pharmacology and Experimental Validation Approach.逍遥散结汤治疗三阴性乳腺癌的作用机制及疗效揭示:基于网络药理学和实验验证的方法
Drug Des Devel Ther. 2024 Dec 27;18:6263-6281. doi: 10.2147/DDDT.S492047. eCollection 2024.
8
Metformin and the PI3K/AKT signaling pathway: implications for cancer, cardiovascular, and central nervous system diseases.二甲双胍与PI3K/AKT信号通路:对癌症、心血管疾病和中枢神经系统疾病的影响
Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb;398(2):1035-1055. doi: 10.1007/s00210-024-03358-3. Epub 2024 Sep 3.
9
The Role of the PI3K/Akt/mTOR Axis in Head and Neck Squamous Cell Carcinoma.PI3K/Akt/mTOR轴在头颈部鳞状细胞癌中的作用
Biomedicines. 2024 Jul 19;12(7):1610. doi: 10.3390/biomedicines12071610.
10
Clinical applications of next-generation sequencing-based ctDNA analyses in breast cancer: defining treatment targets and dynamic changes during disease progression.基于下一代测序的循环肿瘤DNA分析在乳腺癌中的临床应用:确定治疗靶点及疾病进展过程中的动态变化
Mol Oncol. 2024 Jun 12. doi: 10.1002/1878-0261.13671.
作为激素受体阳性、HER2阴性转移性乳腺癌分子靶点的突变
Front Oncol. 2021 Mar 25;11:644737. doi: 10.3389/fonc.2021.644737. eCollection 2021.
4
Targeting ACLY Attenuates Tumor Growth and Acquired Cisplatin Resistance in Ovarian Cancer by Inhibiting the PI3K-AKT Pathway and Activating the AMPK-ROS Pathway.靶向ACLY通过抑制PI3K-AKT通路和激活AMPK-ROS通路减弱卵巢癌的肿瘤生长和获得性顺铂耐药性。
Front Oncol. 2021 Mar 17;11:642229. doi: 10.3389/fonc.2021.642229. eCollection 2021.
5
Role of Src/FAK in migration and invasion mediated by extracellular vesicles from MDA-MB-231 cells stimulated with linoleic acid.Src/FAK 在由富含亚油酸的 MDA-MB-231 细胞外囊泡刺激的迁移和侵袭中的作用。
Med Oncol. 2021 Mar 16;38(4):40. doi: 10.1007/s12032-021-01485-y.
6
Knockdown of AKT3 Activates HER2 and DDR Kinases in Bone-Seeking Breast Cancer Cells, Promotes Metastasis In Vivo and Attenuates the TGFβ/CTGF Axis.敲低 AKT3 在骨趋向性乳腺癌细胞中激活 HER2 和 DDR 激酶,促进体内转移并减弱 TGFβ/CTGF 轴。
Cells. 2021 Feb 18;10(2):430. doi: 10.3390/cells10020430.
7
PPAR-gamma induced AKT3 expression increases levels of mitochondrial biogenesis driving prostate cancer.过氧化物酶体增殖物激活受体-γ(PPAR-γ)诱导 AKT3 表达增加,促进了线粒体生物发生,从而驱动前列腺癌的发生。
Oncogene. 2021 Apr;40(13):2355-2366. doi: 10.1038/s41388-021-01707-7. Epub 2021 Mar 2.
8
Hsa_circ_0000199 facilitates chemo-tolerance of triple-negative breast cancer by interfering with miR-206/613-led PI3K/Akt/mTOR signaling.Hsa_circ_0000199 通过干扰 miR-206/613 介导的 PI3K/Akt/mTOR 信号通路促进三阴性乳腺癌的化疗耐受。
Aging (Albany NY). 2021 Jan 20;13(3):4522-4551. doi: 10.18632/aging.202415.
9
An AKT2-specific nanobody that targets the hydrophobic motif induces cell cycle arrest, autophagy and loss of focal adhesions in MDA-MB-231 cells.一种针对 AKT2 特定疏水基序的纳米抗体可诱导 MDA-MB-231 细胞周期停滞、自噬和焦点黏附丧失。
Biomed Pharmacother. 2021 Jan;133:111055. doi: 10.1016/j.biopha.2020.111055. Epub 2020 Dec 7.
10
AKT1 E17K Inhibits Cancer Cell Migration by Abrogating β-Catenin Signaling.AKT1 E17K 通过阻断 β-连环蛋白信号抑制癌细胞迁移。
Mol Cancer Res. 2021 Apr;19(4):573-584. doi: 10.1158/1541-7786.MCR-20-0623. Epub 2020 Dec 10.